Perbedaan Ciputra Development Tbk dan Brigit Biofarmaka Teknologi Tbk.: Ciputra Development Tbk diperdagangkan di Rp570 (kapitalisasi pasar 10,38 T, volume 24 jam 7,43 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp244 (kapitalisasi pasar 167,37 M, volume 24 jam 40,2 rb). Perbedaan utamanya: Ciputra Development Tbk jauh lebih besar — sekitar 62× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Ciputra Development Tbk lebih aktif diperdagangkan (7,43 jt vs 40,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CTRA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 10,38 T | 167,37 M |
Volume | 7,43 jt | 40,2 rb |
Lot | 74,32 rb | 402 |
Perputaran | 4,26 M | 9,91 jt |
Harga Rata-rata | 573,06 | 246,61 |
Nilai Transaksi | 4,26 M | 9,91 jt |
Harga Ekuilibrium Indikatif | 565 | 246 |
Volume Ekuilibrium Indikatif | 819 | 2,4 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Selengkapnya di halaman CTRA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →